Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Study: Minority groups remain conspicuously absent from pancreatic cancer clinical trials

Study: Minority groups remain conspicuously absent from pancreatic cancer clinical trials

Understanding hypoxia-induced gene expression variations in aggressive type of pancreatic cancer

Understanding hypoxia-induced gene expression variations in aggressive type of pancreatic cancer

New immunotherapy strategy can eliminate pancreatic tumors in mice

New immunotherapy strategy can eliminate pancreatic tumors in mice

Anti-parasitic drug prevents pancreatic cancer's initiation, progression and metastasis in mice

Anti-parasitic drug prevents pancreatic cancer's initiation, progression and metastasis in mice

Removing RNA-binding protein in subtype of leukemia can help to slow the cancer's development

Removing RNA-binding protein in subtype of leukemia can help to slow the cancer's development

Innovative testing platform could enable more precise, personalized immunotherapy

Innovative testing platform could enable more precise, personalized immunotherapy

Virginia Tech graduate student receives NSF grant to examine new treatments for pancreatic cancer

Virginia Tech graduate student receives NSF grant to examine new treatments for pancreatic cancer

Tissue-specific genetic interactions drive different types of cancer development

Tissue-specific genetic interactions drive different types of cancer development

Selective immunotoxins may help treat liver fibrosis

Selective immunotoxins may help treat liver fibrosis

Stimulating immune cells to form special structures can potentiate pancreatic cancer chemotherapy

Stimulating immune cells to form special structures can potentiate pancreatic cancer chemotherapy

University of Liverpool signs option agreement with BARD1 for type 3C diabetes test

University of Liverpool signs option agreement with BARD1 for type 3C diabetes test

New method expands view into activity of single cells

New method expands view into activity of single cells

New study to test the scalability of offering preventive DNA screening to young adults for cancer risk

New study to test the scalability of offering preventive DNA screening to young adults for cancer risk

Loss of PTHrP hormone can prevent metastases, improve survival in mice with pancreatic cancer

Loss of PTHrP hormone can prevent metastases, improve survival in mice with pancreatic cancer

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

New resource could make targeted cancer therapies more accessible for Australian patients

New resource could make targeted cancer therapies more accessible for Australian patients

CSHL researchers discover how pancreatic cancer cells develop resistance to drug treatments

CSHL researchers discover how pancreatic cancer cells develop resistance to drug treatments

Novel drug class shows potential to treat cancer patients with faulty BRCA genes

Novel drug class shows potential to treat cancer patients with faulty BRCA genes

Study uncovers novel drug that effectively thwarts pancreatic tumors

Study uncovers novel drug that effectively thwarts pancreatic tumors

Scientists develop new method for single-cell lineage tracing of metastatic cancer

Scientists develop new method for single-cell lineage tracing of metastatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.